Publication: Long-term risk of adverse outcomes according to atrial fibrillation type.
cris.virtualsource.author-orcid | bd5c5635-aa7c-4beb-b359-c9b8b5ebba35 | |
cris.virtualsource.author-orcid | dcf039b3-51b9-457e-aa4f-439d935925b3 | |
datacite.rights | open.access | |
dc.contributor.author | Blum, Steffen | |
dc.contributor.author | Aeschbacher, Stefanie | |
dc.contributor.author | Coslovsky, Michael | |
dc.contributor.author | Meyre, Pascal B | |
dc.contributor.author | Reddiess, Philipp | |
dc.contributor.author | Ammann, Peter | |
dc.contributor.author | Erne, Paul | |
dc.contributor.author | Moschovitis, Giorgio | |
dc.contributor.author | Di Valentino, Marcello | |
dc.contributor.author | Shah, Dipen | |
dc.contributor.author | Schläpfer, Jürg | |
dc.contributor.author | Müller, Rahel | |
dc.contributor.author | Beer, Jürg H | |
dc.contributor.author | Kobza, Richard | |
dc.contributor.author | Bonati, Leo H | |
dc.contributor.author | Moutzouri Beifuss, Elisavet | |
dc.contributor.author | Rodondi, Nicolas | |
dc.contributor.author | Meyer-Zürn, Christine | |
dc.contributor.author | Kühne, Michael | |
dc.contributor.author | Sticherling, Christian | |
dc.contributor.author | Osswald, Stefan | |
dc.contributor.author | Conen, David | |
dc.date.accessioned | 2024-10-09T16:51:16Z | |
dc.date.available | 2024-10-09T16:51:16Z | |
dc.date.issued | 2022-02-09 | |
dc.description.abstract | Sustained forms of atrial fibrillation (AF) may be associated with a higher risk of adverse outcomes, but few if any long-term studies took into account changes of AF type and co-morbidities over time. We prospectively followed 3843 AF patients and collected information on AF type and co-morbidities during yearly follow-ups. The primary outcome was a composite of stroke or systemic embolism (SE). Secondary outcomes included myocardial infarction, hospitalization for congestive heart failure (CHF), bleeding and all-cause mortality. Multivariable adjusted Cox proportional hazards models with time-varying covariates were used to compare hazard ratios (HR) according to AF type. At baseline 1895 (49%), 1046 (27%) and 902 (24%) patients had paroxysmal, persistent and permanent AF and 3234 (84%) were anticoagulated. After a median (IQR) follow-up of 3.0 (1.9; 4.2) years, the incidence of stroke/SE was 1.0 per 100 patient-years. The incidence of myocardial infarction, CHF, bleeding and all-cause mortality was 0.7, 3.0, 2.9 and 2.7 per 100 patient-years, respectively. The multivariable adjusted (a) HRs (95% confidence interval) for stroke/SE were 1.13 (0.69; 1.85) and 1.27 (0.83; 1.95) for time-updated persistent and permanent AF, respectively. The corresponding aHRs were 1.23 (0.89, 1.69) and 1.45 (1.12; 1.87) for all-cause mortality, 1.34 (1.00; 1.80) and 1.30 (1.01; 1.67) for CHF, 0.91 (0.48; 1.72) and 0.95 (0.56; 1.59) for myocardial infarction, and 0.89 (0.70; 1.14) and 1.00 (0.81; 1.24) for bleeding. In this large prospective cohort of AF patients, time-updated AF type was not associated with incident stroke/SE. | |
dc.description.numberOfPages | 8 | |
dc.description.sponsorship | Clinic of General Internal Medicine | |
dc.description.sponsorship | Berner Institut für Hausarztmedizin (BIHAM) | |
dc.identifier.doi | 10.48350/165476 | |
dc.identifier.pmid | 35140237 | |
dc.identifier.publisherDOI | 10.1038/s41598-022-05688-9 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/67436 | |
dc.language.iso | en | |
dc.publisher | Springer Nature | |
dc.relation.ispartof | Scientific reports | |
dc.relation.issn | 2045-2322 | |
dc.relation.organization | Clinic of General Internal Medicine | |
dc.relation.organization | DCD5A442BDB9E17DE0405C82790C4DE2 | |
dc.relation.organization | DCD5A442C058E17DE0405C82790C4DE2 | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.subject.ddc | 300 - Social sciences, sociology & anthropology::360 - Social problems & social services | |
dc.title | Long-term risk of adverse outcomes according to atrial fibrillation type. | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 2208 | |
oaire.citation.volume | 12 | |
oairecerif.author.affiliation | Berner Institut für Hausarztmedizin (BIHAM) | |
oairecerif.author.affiliation | Berner Institut für Hausarztmedizin (BIHAM) | |
oairecerif.author.affiliation2 | Clinic of General Internal Medicine | |
oairecerif.author.affiliation2 | Clinic of General Internal Medicine | |
oairecerif.author.affiliation3 | Clinic of General Internal Medicine | |
unibe.additional.sponsorship | Clinic of General Internal Medicine | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2022-02-14 16:30:20 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 165476 | |
unibe.journal.abbrevTitle | SCI REP | |
unibe.refereed | true | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- Blum_SciRep_2022.pdf
- Size:
- 1.01 MB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- https://creativecommons.org/licenses/by/4.0
- Content:
- published